FDA Approves ‘First and Only’ Esophageal Oral Drug After Earlier Rejection

The manufacturer earlier abandoned the drug’s development following the initial rejection by the federal agency.

The logo of Takeda Pharmaceutical Co. Japan May 9, 2018. Kim Kyung-Hoon/Reuters

The U.S. Food and Drug Administration (FDA) has approved a medication for an esophageal disease that makes it difficult to swallow food.

The FDA approved Eohilia for use among individuals aged 11 years and older who have eosinophilic esophagitis (EoE), Japan-based Takeda Pharmaceutical said in a Feb. 12 press release.